Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Attention-deficit/Hyperactivity Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05243186
What this trial is testing

Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill

Who this might be right for
Attention Deficit Disorder
Ariel University 30
Large-scale testing (Phase 3)Study completedNCT02059642
What this trial is testing

A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

Who this might be right for
ADHDAttention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
Alcobra Ltd. 300
Post-approval studies (Phase 4)Study completedNCT01673594
What this trial is testing

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

Who this might be right for
ADHDStimulant-Induced Euphoria
Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Study completedNCT01074294
What this trial is testing

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 740
Large-scale testing (Phase 3)Study completedNCT01259492
What this trial is testing

Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit/Hyperactivity Disorder
Novartis Pharmaceuticals 725
Testing effectiveness (Phase 2)Study completedNCT02547428
What this trial is testing

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Otsuka Pharmaceutical Development & Commercialization, Inc. 85
Not applicableWithdrawnNCT01629914
What this trial is testing

Executive Functioning and Mindfulness in Adults With Attention Deficit/Hyperactivity Disorder Imaging

Who this might be right for
Attention-deficit/Hyperactivity Disorder
Duke University
Large-scale testing (Phase 3)Study completedNCT00326300
What this trial is testing

A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 560
Large-scale testing (Phase 3)Study completedNCT03659929
What this trial is testing

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

Who this might be right for
Attention Deficit Hyperactivity Disorder
Arbor Pharmaceuticals, Inc. 320
Post-approval studies (Phase 4)WithdrawnNCT01207622
What this trial is testing

Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD

Who this might be right for
Attention Deficit Hyperactivity DisorderSubstance Use Disorder
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT00307684
What this trial is testing

Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Janssen-Cilag International NV 155
Not applicableStudy completedNCT06030024
What this trial is testing

Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder

Who this might be right for
Attention Deficit DisorderADHD
University of Tehran 10
Not applicableStudy completedNCT00181857
What this trial is testing

Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)

Who this might be right for
ADHD
Massachusetts General Hospital 58
Not applicableStudy completedNCT05206734
What this trial is testing

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

Who this might be right for
Inflammatory Bowel DiseasesDepressive EpisodeRecurrent Depressive Disorder+15 more
Momentum Data 19,469
Large-scale testing (Phase 3)Ended earlyNCT02477748
What this trial is testing

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Alcobra Ltd. 283
Post-approval studies (Phase 4)Study completedNCT00510276
What this trial is testing

Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 445
Large-scale testing (Phase 3)Study completedNCT02604407
What this trial is testing

Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Shire 275
Not applicableStudy completedNCT01852357
What this trial is testing

An Evaluation of Neurofeedback Efficacy in Adults With ADHD

Who this might be right for
ADHD
University of North Carolina, Wilmington 30
Post-approval studies (Phase 4)Study completedNCT00190775
What this trial is testing

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 502
Post-approval studies (Phase 4)Study completedNCT00190957
What this trial is testing

Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

Who this might be right for
ADHDComorbid Alcohol Abuse
Eli Lilly and Company 140
Next Page